Opendata, web and dolomites

TOTIPOTENCY2014

Dissecting the epigenetic control of totipotency.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TOTIPOTENCY2014 project word cloud

Explore the words cloud of the TOTIPOTENCY2014 project. It provides you a very rough idea of what is the project "TOTIPOTENCY2014" about.

enhancer    mammalian    validating    epigenetic    stem    relevance    analysed    mechanisms    data    somatic    cells    remodelling    insights    regulation    murine    interaction    embryo    totipotency    bioinformatic    restoring    additional    genes    single    therapy    occurs    cell    sub    efficiency    embryonic    interdependencies    contain    expressing    gene    technologies    mechanistic    am    uses    screened    poorly    expression    one    medicine    previously    fidelity    newly    critical    researcher    model    chromatin    systematically    regulators    escs    34    implantation    differentiation    host    experimentally    transcriptome    expands    potentially    lab    tractable    rare    shortlisted    fertilization    determined    mechanistically    regenerative    stage    expertise    combines    population    contribution    enhanced    enhancers    validated    epigenetics    limited    proteins    developmental    confirmed    action    biology    capability    innovative    cutting    extra    firstly    reprogramming    restricted    edge    eel    normally    personalised    mode    lack    vitro    shortly   

Project "TOTIPOTENCY2014" data sheet

The following table provides information about the project.

Coordinator
THE BABRAHAM INSTITUTE 

Organization address
address: Babraham Hall
city: CAMBRIDGE
postcode: CB22 3AT
website: www.babraham.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.babraham.ac.uk/our-research/epigenetics/wolf-reik
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2017-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE BABRAHAM INSTITUTE UK (CAMBRIDGE) coordinator 183˙454.00

Map

 Project objective

One of the most critical epigenetic and chromatin remodelling processes in mammalian development occurs shortly after fertilization restoring totipotency. Due to limited cell numbers and lack of experimentally tractable systems, the mechanisms and regulation of this developmental stage are poorly understood. This proposal will provide important mechanistic insights into the epigenetic control of early embryonic gene expression, and its relevance to somatic reprogramming.

Murine embryonic stem cells (ESCs) contain a rare sub-population of early embryonic like (EEL) cells expressing genes normally restricted to the pre-implantation embryo, with enhanced extra-embryonic differentiation capability. Firstly, using novel single-cell technologies, I will characterize the EEL cells in detail, validating them as an in vitro model of pre-implantation development. On-going research in the host lab that I am involved in has identified an epigenetic enhancer that expands this EEL sub-population. Through bioinformatic analysis of pre-implantation transcriptome data, I have shortlisted 34 epigenetic and chromatin-associated proteins, including the previously identified factor, which will be systematically screened to identify new enhancers of totipotency. Validated EEL regulators, including two additional newly confirmed factors, will be analysed mechanistically determining their interaction partners, interdependencies, and mode of action. Finally, the contribution of the totipotency regulators towards the efficiency and fidelity of somatic reprogramming will be determined, potentially improving the use of this technology for personalised gene therapy and regenerative medicine.

This state-of-the-art proposal uses innovative and novel cutting-edge technologies and combines the expertise of the researcher and the host. It has the potential for significant impact across several fields from epigenetics and stem cell biology to reprogramming and regenerative medicine.

 Publications

year authors and title journal last update
List of publications.
2016 Mélanie A. Eckersley-Maslin, Valentine Svensson, Christel Krueger, Thomas M. Stubbs, Pascal Giehr, Felix Krueger, Ricardo J. Miragaia, Charalampos Kyriakopoulos, Rebecca V. Berrens, Inês Milagre, Jörn Walter, Sarah A. Teichmann, Wolf Reik
MERVL/Zscan4 Network Activation Results in Transient Genome-wide DNA Demethylation of mESCs
published pages: 179-192, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2016.08.087
Cell Reports 17/1 2019-06-14

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TOTIPOTENCY2014" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TOTIPOTENCY2014" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Widow Spider Mating (2020)

Immature mating as a novel tactic of an invasive widow spider

Read More  

CP-FTmmW Aminogen (2020)

Chemistry and structure of aminogen radicals using chirped-pulse Fourier transform (sub)millimeter rotational spectroscopy

Read More  

TARGET SLEEP (2020)

Boosting motor learning through sleep and targeted memory reactivation in ageing and Parkinson’s disease

Read More